Schering Claritin-D 24-hour swallowing difficulty addressed anew in July 23 "Dear Doctor" letter.
Executive Summary
SCHERING CLARITIN-D 12-HOUR MAY BE USED IN PATIENTS WITH SWALLOWING DIFFICULTY who should not receive the 24-hour version of the loratadine/pseudoephedrine product, the company says in a July 23 "Dear Doctor" letter to prescribers. "For these patients, you may want to consider prescribing Claritin-D 12-hour (5 mg loratadine/120 mg pseudoephedrine sulfate, USP) extended-release tablets instead of Claritin-D 24-hour," the letter states.